• Summary

    Nanodiamonds (NDs) are solid nano-entities of stable core and tunable surface. NDs
    mediated anticancer drug delivery has been under the focus of scientific community due to their
    ability to boost the chemosensitivity of anticancer drugs by sustaining their release and masking
    them from the effect of efflux pumps. In the present study proposal, NDs are being employed
    for the delivery of a chemotherapeutic drug for the treatment of lung cancer. The safety of
    pulmonary delivery of different types of drug-free NDs will primarily be evaluated both in vitro
    and in vivo. Then, NDs loading with chemotherapeutic agent and targeting moiety will be
    carried out and the resultant nanoparticles will be characterized. The produced nanoparticles
    suspension will then be studied for pulmonary delivery either directly by nebulization or by
    spray drying with suitable excipients to yield powder for inhalation. In both strategies, the
    aerodynamic diameter of the produced aerosol droplets or microspheres will be evaluated.
    Finally, a pharmacokinetic study will be carried out to compare the amount of chemotherapeutic
    drug delivered to lung in case of intravenous or pulmonary delivery.

  • Achievements


  • List of Publications from the Project


  • Partners

  • Project Members

  • Project Leaders

  • Project PI

    Maha Nasr

  • Faculty

    Faculty of Pharmacy

  • Research Group

  • Funding Agency

    STDF / STIFA

  • Funding Program

    Young Researchers Grant (STDF-YRG)

  • Start Date

    2020-12-27

  • End Date

    2022-04-13

  • Sustainable Development Goals (SDGs)

  • Project website